{"title":"Reversal of multidrug resistance using poly(L-lactide)-vitamin E TPGS micelles in breast cancer cell","authors":"P. Y. Li, P. Lai, C. Lin","doi":"10.1109/ICBPE.2009.5384064","DOIUrl":null,"url":null,"abstract":"Drug resistance is a frequent clinical problem that seriously reduces the efficacy of many chemotherapy agents. In this study, the effect of micellar encapsulation using poly(L-lactide)-vitamin E TPGS (PLA-TPGS) copolymer on intracellular distribution of doxorubicin was studied in vitro. As our results, doxorubicin can be encapsulated successfully into PLA-TPGS formed micelle with a uniform particle size (≪ 200nm) that could exhibit the passive targeting ability to cancer tissue. Moreover, the nuclear accumulation of doxorubicin can be improved significantly in micelle form that can utilize as a potential carrier to overcome doxorubicin-resistance in breast MCF-7 cancer cells.","PeriodicalId":384086,"journal":{"name":"2009 International Conference on Biomedical and Pharmaceutical Engineering","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2009 International Conference on Biomedical and Pharmaceutical Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICBPE.2009.5384064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
Drug resistance is a frequent clinical problem that seriously reduces the efficacy of many chemotherapy agents. In this study, the effect of micellar encapsulation using poly(L-lactide)-vitamin E TPGS (PLA-TPGS) copolymer on intracellular distribution of doxorubicin was studied in vitro. As our results, doxorubicin can be encapsulated successfully into PLA-TPGS formed micelle with a uniform particle size (≪ 200nm) that could exhibit the passive targeting ability to cancer tissue. Moreover, the nuclear accumulation of doxorubicin can be improved significantly in micelle form that can utilize as a potential carrier to overcome doxorubicin-resistance in breast MCF-7 cancer cells.